Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Pro Medicus Limited ( (AU:PME) ) is now available.
Pro Medicus Limited has announced an update regarding its ongoing buy-back program, detailing the acquisition of 3,865 ordinary fully paid securities on the previous day, bringing the total bought back to 23,317. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$320.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software solutions for medical professionals. The company focuses on delivering innovative products that enhance diagnostic imaging capabilities, catering primarily to healthcare providers and institutions.
Average Trading Volume: 180,280
Technical Sentiment Signal: Buy
Current Market Cap: A$26.94B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.